Related Experiment Videos
Pathobiology of the senescence-accelerated mouse (SAM)
T Takeda1, T Matsushita, M Kurozumi
1Department of Senescence Biology, Kyoto University, Japan.
Experimental Gerontology
|January 1, 1997
Summary
The senescence accelerated mouse (SAM) model exhibits distinct age-associated pathologies, aiding research into aging mechanisms. These findings support the development of interventions for age-related diseases.
Area of Science:
- Gerontology
- Pathobiology
- Animal Models
Background:
- The senescence accelerated mouse (SAM) model is characterized by accelerated aging phenotypes.
- Understanding the specific pathologies across different SAM substrains is crucial for aging research.
Purpose of the Study:
- To systematically document and differentiate the pathobiological features of various SAM substrains.
- To highlight the utility of the SAM model in studying age-associated diseases.
Main Methods:
- Routine postmortem examinations.
- Systematically designed studies to reveal pathobiological features.
- Monitoring of age-associated pathologies in SAM substrains.
Main Results:
- Distinct pathologic phenotypes were identified in various SAM substrains, including senile amyloidosis, contracted kidney, lymphoma, sarcoma, ovarian cysts, immune impairment, lung hyperinflation, hearing impairment, joint disease, osteoporosis, learning/memory deficits, emotional disorders, cataracts, and brain atrophy.
- The incidence and severity of these age-associated pathologies increase with age.
- Specific SAM substrains exhibit characteristic age-related disease profiles.
Conclusions:
- The SAM model provides a valuable platform for clarifying the pathogenic mechanisms of age-associated diseases.
- This model can facilitate research into effective methods for modulating or ameliorating age-related pathologies.
- Detailed characterization of SAM substrain pathologies is essential for advancing aging research.